ArticleOncology letters2012

Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer.

Daniel T Rein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.